Co-Diagnostics, Inc.

CODX OTC CIK: 0001692415

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation UT
Business Address 4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY, UT, 84124
Mailing Address 4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY, UT, 84124
Phone 8012789769
Fiscal Year End 1231
EIN 462609396

Financial Overview

FY2024

-$35.33M
Net Income
$95.32M
Total Assets
$9.69M
Total Liabilities
$-1.24
EPS

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 11, 2026 View on SEC
8-K Current report of material events January 13, 2026 View on SEC
8-K Current report of material events December 30, 2025 View on SEC
424B5 Prospectus supplement December 19, 2025 View on SEC
8-K Current report of material events December 5, 2025 View on SEC
4 Insider stock transaction report November 24, 2025 View on SEC
4 Insider stock transaction report November 24, 2025 View on SEC
4 Insider stock transaction report November 24, 2025 View on SEC
4 Insider stock transaction report November 24, 2025 View on SEC
4 Insider stock transaction report November 24, 2025 View on SEC

Material Events

8-K Strategy Change December 30, 2025
High Impact
  • Co-Diagnostics, Inc. announced a 1-for-30 reverse stock split.
  • The split will become effective at the end of January 1, 2026, with shares trading on a split-adjusted basis starting January 2, 2026.
View Analysis
8-K Strategy Change December 5, 2025
High Impact
  • Co-Diagnostics' shareholders approved a reverse stock split plan.
  • The Board of Directors has up to 12 months to decide the exact ratio, ranging from 1-for-2 to 1-for-30.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.